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Results carnosine increased in the gastrocnemius (n = 5) 
(p = 0.03) and soleus (n = 5) (p = 0.02) following BAl 
supplementation, and Pl-SB and BAl-SB ingestion elevated 
blood HcO3− concentrations (p < 0.01). Although buff-
ering capacity was elevated following both BAl and SB 
ingestion, performance improvement was only observed 
with BAl-Pl and BAl-SB increasing time to exhaustion of 
the cct110 % test 14 and 16 %, respectively, compared to 
Pl–Pl (p < 0.01).
Conclusion Supplementation of BAl and SB elevated 
buffering potential by increasing muscle carnosine and 
blood bicarbonate levels, respectively. BAl ingestion 
improved performance during the cct110 %, with no 
aggregating effect of SB supplementation (p > 0.05). Per-
formance was not different between treatments during the 
rSA test.
Keywords Beta-alanine · carnosine · Bicarbonate ·  
High-intensity exercise · Metabolism
Abbreviations
AnOVA  Analysis of variance
APO  Average power output
BAl-Pl  β-Alanine + calcium carbonate
BAl-SB  β-Alanine + sodium bicarbonate
cct110 %  cycling capacity test
HIE  High-intensity exercise
MrS  Magnetic resonance spectroscopy
Pl-Pl  calcium carbonate + calcium carbonate
Pl-SB  calcium carbonate + sodium bicarbonate
PPO  Peak power output
rSA  repeated sprint ability
ttE  time to exhaustion
VO2peak  Peak oxygen consumption
Abstract 
Introduction β-alanine (BAl) and naHcO3 (SB) ingestion 
may provide performance benefits by enhancing concen-
trations of their respective physiochemical buffer counter-
parts, muscle carnosine and blood bicarbonate, counteract-
ing acidosis during intense exercise. this study examined 
the effect of BAl and SB co-supplementation as an ergo-
genic strategy during high-intensity exercise.
Methods Eight healthy males ingested either BAl 
(4.8 g day−1 for 4 weeks, increased to 6.4 g day−1 for 
2 weeks) or placebo (Pl) (cacO3) for 6 weeks, in a crosso-
ver design (6-week washout between supplements). After 
each chronic supplementation period participants per-
formed two trials, each consisting of two intense exercise 
tests performed over consecutive days. trials were sepa-
rated by 1 week and consisted of a repeated sprint abil-
ity (rSA) test and cycling capacity test at 110 % Wmax 
(cct110 %). Placebo (Pl) or SB (300 mg kgbw−1) was 
ingested prior to exercise in a crossover design to creat-
ing four supplement conditions (BAl-Pl, BAl-SB, Pl–Pl, 
Pl-SB).
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Introduction
High-intensity exercise (HIE) results in the accumulation 
of glycolytic metabolites as a consequence of anaerobic 
metabolism during times of limited oxygen availability to 
the working cell (coso et al. 2010; Sweeney et al. 2010). 
Although not the primary cause, an increased acidity of 
the working cells caused by hydrogen ions (H+) accumu-
lation as by-products of anaerobic metabolism has poten-
tially deleterious effects implicated in fatigue (Begum 
et al. 2005; Bishop et al. 2004) and can lead to significant 
impairments to exercise performance at high intensities 
(robergs et al. 2005). Potential limiting factors result-
ing from acidosis include direct influences on contraction 
within the muscle cell due to competition of the H+ with 
calcium ion (ca2+) (Fabiato and Fabiato 1978), inhibition 
of glycolytic enzymes (Sutton et al. 1981) and Pcr recov-
ery (Harris et al. 1976), and its interference to the buffering 
process (Sahlin and Harris 2011).
Intramuscular pH homeostasis is achieved by active 
and passive transport of H+ out of the muscle cell into 
the surrounding interstitium by physiochemical buffers, 
which work to maintain pH within a range for optimal 
enzyme function by tempering the effect of acidosis in 
the intracellular and extracellular milieu during HIE (Hill 
et al. 2007; Siegler et al. 2010). Physiochemical buffers 
include muscle carnosine, which plays an immediate role 
due to its intracellular location, and blood bicarbonate 
(HcO3−), which has an extracellular presence (Sale et al. 
2010).
carnosine (β-alanyl-l-histidine) is found in relatively 
high concentrations in human skeletal muscles at around 
5–10 mmol kg−1 wet weight (ww) (Boldyrev and Severin 
1990; Harris et al. 2006; Hill et al. 2007). It is endoge-
nously synthesised from β-alanine (the limiting precursor 
in its synthesis) and l-histidine, and contributes between 
8 and 15 % of the endogenous H+ buffering capacity 
(Van thienen et al. 2009; Baguet et al. 2010). Its syn-
thesis is slow and can take several weeks to accumulate 
in the muscle, warranting the need for chronic supple-
mentation of β-alanine (Baguet et al. 2009; Derave et al. 
2007). Increases in intense exercise performance follow-
ing β-alanine ingestion indicate the potential of its influ-
ence on the intracellular pH buffer capacity via elevated 
carnosine concentrations (Hill et al. 2007; Sale et al. 
2010; Sweeney et al. 2010). Although specific cellular 
mechanism(s) of the action and the consequential ben-
efit to exercise performance remains unclear, elevated 
carnosine has also been linked to various additional cel-
lular functions including, the regulation of ca2+ sensitiv-
ity (Boldyrev and Severin 1990; Johnson and Aldstaft 
1984), the protection of protein glycosylation by acting 
as a sacrificial peptide (Hipkiss et al. 1995), the inhibition 
of protein cross-linking by reacting with protein–carbonyl 
groups (Hipkiss 2000), and free radical scavenging by act-
ing as an antioxidant (chasovnikova et al. 1990).
Blood HcO3− is important for maintaining the homeo-
static acid-base balance in the body (Mcnaughton et al. 
2008). It also plays a role in attenuating the influence of the 
acute acid load following intense exercise once intracellu-
lar buffering capacity is exceeded and H+ diffuses into the 
bloodstream (Juel et al. 2004; Swank and robertson 1989), 
and may inevitably assist in postponing the potential effects 
of fatigue (Mcnaughton et al. 2008; Swank and robertson 
1989). thus, the concentration of HcO3− present in the 
blood prior to exercise potentially influences both extracel-
lular buffering capacity and the extent to which the H+ is 
able to diffuse out of the active muscle (Price et al. 2003). 
naHcO3 ingestion has the potential to influence skel-
etal muscle function and prolong performance due to an 
improvement in blood buffering potential via the creation 
of an enhanced electro-chemical pH gradient between the 
intracellular and extracellular milieu, consequently allow-
ing for a greater efflux of H+ out of the muscle cell (Bishop 
et al. 2004; Price et al. 2003).
combined nutritional strategies which enhance mus-
cle carnosine and blood HcO3− content, such as oral sup-
plementation of β-alanine and naHcO3, respectively, are 
therefore potentially ergogenic, particularly during HIE 
protocols with high glycolytic contribution, where acido-
sis may be a limiting factor to exercise performance (Price 
and Simons 2010; Sale et al. 2011). Although many pre-
vious studies have investigated the use of either β-alanine 
or naHcO3 independently in improving parameters asso-
ciated with HIE, little is known regarding the ergogenic 
effects of their co-ingestion.
Whilst recently published reports have examined the 
effects of this ergogenic strategy on continuous bout HIE 
(Bellinger et al. 2012; Sale et al. 2011), no study to date 
has, to the authors knowledge, investigated its effects on 
intermittent HIE or implemented a crossover design to 
account for individual variability. the aim of this study 
was therefore to investigate the effect of the co-con-
sumption of β-alanine and naHcO3 on HIE performance 
in healthy males. It was hypothesised that manipulating 
intra- and extracellular buffering capacity, via the co-
ingestion of β-alanine and naHcO3, respectively, will 
improve HIE performance variables compared to the 
placebo condition or the ingestion of either supplement 
alone. the co-consumption of β-alanine and naHcO3 
will buffer acidic by-products generated from anaerobic 
glycolysis, and thus enhance the ability to perform dur-
ing both an intense intermittent and continuous exercise 
bout.
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Methods
Participants
Eight apparently healthy, recreationally active males 
(26.2 ± 1.9 year; 79.8 ± 2.11 kg; 179.0 ± 2.2 cm; VO2peak 
51.0 ± 2.5 ml kg−1 min−1) volunteered to take part in 
this study, which was approved by the Victoria University 
Human research Ethics committee (HrEtH 11/11) and 
performed in accordance with the ethical standards set 
out in the 1964 Declaration of Helsinki. After completing 
a medical questionnaire, each participant signed informed 
consent forms and presented for preliminary testing.
Participants were asked to refrain from consuming caf-
feine and alcohol, and from undertaking strenuous exercise 
24 h prior to all experimental trials. Participants recorded 
their dietary intake 24 h before the first day of the first 
experimental trial, and were asked to consume a similar 
dietary intake the day prior to all subsequent trials. Experi-
mental trials were conducted in the morning, approximately 
10–12 h after the last meal. A standardised warm-up period 
of 5 min of cycling at 80 W was performed on an Excalibur 
lode cycle ergometer (netherlands) before each trial, fol-
lowed by 5 min rest. All tests were followed by 60 min pas-
sive recovery in a supine position.
Preliminary testing
Peak oxygen consumption (VO2peak) was determined 
approximately 1 week before the beginning of each chronic 
supplementation period. A standard graded exercise proto-
col on a Excalibur lode cycle ergometer (netherlands) of 
3 × 3 min sub-maximal workloads at 50, 100 and 150 W 
followed by successive 1-min workload increments of 
25 W until volitional exhaustion. Participants were encour-
aged to maintain a pedal frequency between 80 and 100 
rPM and the test was terminated when rPM could not 
be maintained >80 rPM for a period of 5 s. Expired air 
was directed by a Hans rudolph valve via a ventilometer 
(Moxus; AEI technologies, Pennsylvania, USA) into a 
mixing chamber and analysed for oxygen and carbon diox-
ide content. Prior to each VO2peak test, the gas analyser 
was calibrated using commercially prepared gas mixtures 
(BOc gases, Australia). Following preliminary testing, 
participants were familiarised with the exercise protocols in 
which they would be participating in during the experimen-
tal trials.
In vivo magnetic resonance spectroscopy (MrS) analysis
MrS was used in this study as a non-invasive quantifi-
cation of human muscle carnosine before and after the 
β-alanine and placebo chronic supplementation periods in 
n = 5 participants (due to access and availability of MrS). 
these measurements were made on a whole body proton 
3 tesla scanner (Siemens trio tim, germany) equipped 
with a flexible knee coil at the royal children’s Hospital 
(Melbourne, Australia). Muscle carnosine concentration 
was quantified in the gastrocnemius and soleus muscles of 
the right leg throughout the study using a voxel of dimen-
sion 40 mm × 30 mm × 12 mm. Data were acquired using 
a standard PrESS sequence with an echo time of 30 ms, 
a relaxation delay of 2,000 ms and 176 transients. Muscle 
carnosine concentration was determined by comparing data 
recorded from the gastrocnemius and soleus muscles to a 
standard curve generated from external carnosine reference 
phantoms for absolute quantification. External carnosine 
reference phantoms contained 6.32, 30.00 and 58.93 mM 
carnosine (Sigma) with sodium azide (nan3) as an anti-
bacterial agent. no correction was made for differences in 
relaxation time.
A line broadening of 1 Hz was applied to the data prior 
to Fourier transformation to reduce any noise which may 
have altered the accuracy of results. Manual phasing was 
then applied before line fitting the spectra of each scan with 
an AMArES algorithm (jMrUI, version 4.0, build 113) 
(naressi et al. 2001; Vanhamme et al. 1997). Peak ampli-
tude (arbitrary scale) and linewidth (lw) results attained 
through this algorithm were then used to determine the sig-
nal intensity (area of each peak) using a lorentzian equa-
tion; (I, Intensity; w, 0.5 × lw at 1/2 maximum height; 2θ0, 
position of peak max):
Each spectrum contained two peaks, corresponding to 
the c2–H and c4–H imidazole protons of carnosine, and 
therefore the signal intensity of each peak was combined 
after adjusting to account for the number of protons in the 
structures giving rise to the peaks. A standard curve was 
then generated based on the concentration of each phan-
tom scan and the signal intensity (area calculated from the 
phantom peak). the apparent concentration of carnosine 
from the gastrocnemius and soleus muscle scans was then 
determined with reference to the standard curve.
Supplementation protocols
the dual supplementation, double-blind, crossover experi-
mental design was randomised for both β-alanine vs. pla-
cebo and naHcO3 vs. placebo (Fig. 1) and all participants 
received the four supplement combinations. Specifically, 
there were two periods of 6-week chronic supplementation 
of capsulated β-alanine (Musashi, Australia) or the pla-
cebo calcium carbonate (cacO3) (E170, Melbourne Food 
Ingredient Depot, Australia) which were separated by a 
minimum washout period of 6 weeks (no supplementation). 
I(2θ) = w2/ w2 + (2θ − 2θ0)2.
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the β-alanine supplementation procedure consisted of 
4.8 g day−1 (6 × 800 mg) for 4 weeks and then 6.4 g day−1 
(8 × 800 mg) for 2 weeks. cacO3 was administered in 
equal mass amounts as β-alanine. Participants were asked 
to spread their consumption of daily doses of β-alanine/
cacO3 evenly throughout the day to avoid any possi-
ble paraesthesia. to facilitate compliance, a supplement 
diary was provided to participants upon commencing each 
chronic supplementation bout.
to investigate the superimposition of naHcO3 with 
β-alanine, the acute administration of naHcO3 (Sodibic, 
Aspen Pharmacare, Australia) occurred following each of 
the 6-week periods of β-alanine and placebo supplemen-
tation. this required two trials of either 300 mg kgbw−1 
naHcO3 or placebo (cacO3) supplementation in a ran-
domised crossover design. this acute supplement inges-
tion was administered 90 min prior to the exercise bouts of 
the respective trials and was split into 6 equal doses over 
the first 50 min of the 90-min pre-exercise period. Partici-
pants were asked to consume 300 ml of water with each 
dose to assist in avoiding potential gastrointestinal side 
effects. these trials were separated by 7 days, performed 
in a randomised order, and β-alanine or respective placebo 
supplementation was extended until the second acute sup-
plementation protocol was completed. Ultimately, the fol-
lowing four supplementation combinations were generated: 
β-alanine + cacO3 (BAl-Pl), β-alanine + naHcO3 (BAl-
SB), cacO3 + cacO3 (Pl–Pl), and cacO3 + naHcO3 
(Pl-SB).
Experimental trial protocols
Participants were asked to complete 2 exercise tests, over 
consecutive days, at the end of each of the aforementioned 
four co-supplement periods (Fig. 1). these tests were 
designed to produce high acid loads whilst allowing exam-
ining the effect of supplementation on both intermittent and 
continuous HIE. the first test, a repeated sprint ability test 
(rSA), consisted of 5 repeats of 6 s maximal effort cycling 
bouts separated by 24 s rest (1:4 work-to-rest ratio). Peak 
and average power output were recorded after each sprint. 
this test was performed using a Wattbike Pro (British 
cycling, nottingham) and the same level of resistance was 
set for all trials (Air Brake 7.0). All sprints were performed 
in the standing position beginning with level pedals and the 
right leg forward, and with strong verbal encouragement. 
During the 24 s recovery intervals between sprints, partici-
pants were instructed to rest passively.
the second exercise test was a cycling capacity test 
(cct110 %) performed at 110 % of the workload achieved 
at VO2peak prior to each chronic supplementation period. 
Participants were required to cycle in a seated position at 
110 % of their peak power output (Wmax) (335.9 ± 16.6 W) 
between 80 and 100 rpm for as long as possible. the clock 
was stopped at the point where their cadence could not be 
sustained above 80 rpm (time to exhaustion; ttE). to over-
come the inertia of the electromagnetic resistance of initial 
exercise at low cadence, the protocol on the electrically 
loaded bike the beginning of the cct110 % was modified to 
begin with 15 s of 80 % Wmax and 15 s of 90 % Wmax before 
110 % Wmax was attained.
Blood sampling, treatment and analysis
Blood was sampled from a vein in the antecubital space 
and the cannula was kept patent with isotonic saline 
(0.9 % nacl, Pfizer). Blood was sampled at rest (pre- and 
post-naHcO3/placebo supplementation), immediately 
after exercise and during a 60 min post exercise recovery 
period. One portion of the blood was immediately placed 
Fig. 1  Design of the study. Each trial consisted of two exercise tests 
performed over consecutive days. A total of 12 weeks between tri-
als 2 and 3 was implemented to ensure adequate supplement wash-
out time participants randomised to ingest β-alanine during the ini-
tial chronic supplementation. MRS Magnetic resonance spectroscopy, 
RSA repeated sprint ability test, CCT110 % cycling capacity test. Solid 
arrows depict crossover between acute supplementation (Pl and SB). 
Dotted arrows depict crossover between chronic supplementation 
(BAl and Pl)
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into lithium heparin (BD Vacutainer) tubes and centrifuged 
at 12,000 rpm for 2 min. Plasma was decanted and stored 
at −80 °c for later analysis of lactate concentration (YSI 
2300 StAt; Yellow Springs Instruments, Ohio, USA). 
Blood pH and HcO3− were analysed immediately using a 
radiometer ABl800 FlEX Blood gas Analyser (ABl800 
FlEX; radiometer Medical, Brønshøj, Denmark).
Statistical analysis
results are expressed as mean ± standard error of the 
mean (SEM). two-way analysis of variance (AnOVA) 
with repeated measures was performed (graphPad Prism 6, 
Windows XP) one within group factor (time or sprint) and 
one between group factor (treatment), for blood, plasma 
and rSA data. Where there was an interaction between the 
factors, tukey’s post hoc analysis was performed. One-
way AVOVA with repeated measures was performed for 
cct110 % and muscle carnosine data (individual × treat-
ment), with paired two-tailed t tests when interactions 
between factors were found. the level of probability 
required to reject the null hypothesis was set at p < 0.05.
Results
Muscle carnosine content
the carnosine concentration was elevated in the gastroc-
nemius and soleus muscles following 6 weeks of sup-
plementation of β-alanine (Fig. 2). In the gastrocnemius 
muscle (Fig. 2a), the absolute carnosine was 8.08 ± 0.68 
and 8.73 ± 1.08 mM in the β-alanine and placebo groups, 
before supplementation, respectively, and increased 
by 5.03 ± 1.44 mM (+62 %, to 13.11 ± 1.97 mM; 
p = 0.03) after supplementation, whereas it remained sta-
ble at 7.42 ± 0.74 mM (p = 0.20) in the placebo group. 
Six weeks of chronic supplementation also caused the 
carnosine content of the soleus muscle (Fig. 2b) to 
increase by 4.92 ± 1.28 mM (+88 %, 5.57 ± 0.25 to 
10.48 ± 1.35 mM; p = 0.02) before and after supplemen-
tation, respectively, in the β-alanine group whilst the car-
nosine concentration of the placebo group did not change 
(+7 %, 5.94 ± 0.56 to 6.33 ± 0.89 mM; p = 0.6). car-
nosine concentrations in both muscle groups were also 
significantly elevated compared to that of the placebo (Pl) 
condition following 6 weeks of supplementation [gastroc-
nemius, +5.69 ± 2.08 (p = 0.05); soleus +4.15 ± 0.78 
(p = 0.006)].
the washout protocol of carnosine from the muscle for 
participants who received β-alanine during the first chronic 
supplementation period (n = 3) was modified at the end of 
the experimental procedures, once the supplementation order 
randomisation was de-coded. this was done to ensure a min-
imum 12-week washout period upon cessation of β-alanine 
supplementation, as estimated from previous research 
(Baguet et al. 2009; Derave et al. 2007). In these partici-
pants, the post-supplementation sample in the second of the 
6-week supplementation periods (placebo) was unmodi-
fied; however, values observed via MrS pre-β-alanine sup-
plementation (initial MrS) were used for baseline data in 
these participants when examining the effect of chronic pla-
cebo supplementation. this was due to the second chronic 
supplementation period beginning during the 6 week of 
the washout period, and hence data collected here did not 
accurately reflected basal muscle carnosine concentrations. 
After a washout of 6 weeks, carnosine concentrations had 
decreased to 10.03 ± 1.34 mM (−19 %) in the gastrocne-
mius and 6.54 ± 0.60 mM (−23 %) in the soleus, at a rate 
of −0.3 mM week−1 and −0.4 mM week−1, respectively. 
twelve weeks following cessation of β-alanine supple-
mentation (end of second chronic supplementation period), 
muscle carnosine concentrations in both the gastrocnemius 
and soleus had returned to baseline concentrations, with 
the average rate of carnosine consistently decreasing in the 
Fig. 2  changes in carnosine 
concentration in the gastroc-
nemius (a) and soleus (b) 
pre- and post-6-week chronic 
supplementation of β-alanine 
(BAl) and placebo (Pl) for 
n = 5. Values expressed as 
mean ± SEM. *p < 0.05 from 
Pl at 6 weeks (post), #p < 0.05 
from pre-supplementation
G a s t r o c n e m iu s
M
us
c
le
C
ar
n
o
s
in
e
(m
M
)
P r
e
Pl
Po
st
Pl
Pr
e
BA
l
Po
st
BA
l
0
5
10
15
20
#
*
A S o le u s
Pr
e
Pl
Po
st
Pl
Pr
e
BA
l
Po
st
BA
l
0
5
1 0
1 5
2 0
#
*
B
1720 Eur J Appl Physiol (2014) 114:1715–1724
1 3
gastrocnemius by 0.5 ± 0.03 mM week−1 and in the soleus 
by 0.4 ± 0.02 mM week−1. this information demonstrates 
that a washout period of 12 weeks was adequate to employ 
a randomised crossover experimental design, with an overall 
average rate of carnosine concentration decrease following 
the cessation of β-alanine supplementation.
Blood HcO3− concentration and pH
there were significant increases in blood HcO3− between 
baseline and the post-supplementation period in both tri-
als involving naHcO3 supplementation (Fig. 3, BAl-SB 
and Pl-SB) (average increase of 3.67 ± 0.46 mmol l−1; 
p ≤ 0.0001). the placebo group showed no changes. the 
blood HcO3− in these groups was also significantly higher 
than that of the placebo condition (Pl–Pl) throughout both 
exercise bouts (p ≤ 0.01). no change was observed in blood 
pH between supplement groups or compared to baseline val-
ues prior to either exercise (Fig. 4). there was an increase in 
both blood HcO3− concentration and blood pH at the end 
of the recovery period following BAl-SB and Pl-SB com-
pared to baseline values and the Pl–Pl condition in both 
exercise bouts (p ≤ 0.01), with the exception of BAl-SB 
blood HcO3− between baseline and 60 min following rSA 
(p = 0.07)). BAl-SB was the only treatment group to show 
significantly higher blood pH values (up to 0.07 ± 0.01 pH 
units; p ≤ 0.0001) throughout the first 10 min of recovery 
compared to Pl–Pl, in both exercise tests.
repeated sprint ability test (rSA)
no differences in peak power output (PPO) or average power 
output (APO) were observed between supplement groups 
during each of the 56-s sprints of the rSA test (table 1). 
there were also no differences in the total work done between 
either or combined supplement groups with a comparison of 
total work done (tW) (BAl-Pl, 22,136.25 ± 1,757.01 J; BAl-
SB, 22,487.00 ± 1,724.30 J; Pl–Pl, 23,586.00 ± 1,831.58 J; 
Pl-SB, 23,068.50 ± 1,749.20 J).
cycling capacity test (cct110 %)
A greater ttE by 18.13 ± 6.75 s (+14 %) (p = 0.005) was 
measured in the BAl-Pl compared to Pl–Pl (147 ± 13.16 
and 129 ± 10.94, respectively) during the cct110 % 
(Fig. 5). Although the addition of naHcO3 to β-alanine 
further increased ttE by 2.75 ± 4.61 s (+2 %) (p = 0.02 
compared to Pl–Pl), there was no statistical difference 
between BAl-Pl and BAl-SB (p = 0.57). no change in ttE 
was determined in Pl-SB treated group (132 ± 13.48 s)
(+2 %) compared to the Pl–Pl condition (p = 0.51).
Plasma lactate
Plasma lactate concentrations (mmol l−1) were elevated in 
all treatment groups following the completion of exercise 
in both the rSA (data not shown) and cct110 % (Fig. 6), 
and remained significantly elevated compared to base-
line at the end of the recovery period. A difference was 
observed at the 5th min of the recovery period following 
the cct110 % protocol, with BAl-SB higher than Pl–Pl by 
2.66 ± 1.20 mmol l−1 (p = 0.04). Although the Pl-SB 
treated groups also showed an apparent increase in plasma 
lactate (+2.28 ± 1.61 mmol l−1) following this test, this 
was non-significant (p = 0.18).
Discussion
this study demonstrated an increase in both intracellu-
lar and extracellular buffering potential following chronic 
β-alanine (6 weeks) and acute naHcO3 (90 min) supple-
mentation, respectively. Furthermore, the combined sup-
plementation induced a similar buffering potential to that 
of the sum of the individual supplementation protocols. 
Improvements in exercise performance following the com-
bined supplementation protocol, however, were equivocal 
and indicate that aggregating the supplementation proto-
col may not have a cumulative effect on physiochemical 
Fig. 3  Blood HcO3− 
(mmol l−1) changes for study 
groups during the repeated 
sprint ability (rSA) and cycling 
capacity test (cct110 %). Values 
expressed as mean ± SEM. 
*p < 0.05 BAl-SB and Pl-SB 
from Pl–Pl, #p < 0.05 BAl-
SB and Pl-SB from PreEx0, 
+p < 0.05 Pl-SB from PreEx0, 
thick vertical bar denotes 
exercise
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buffering capacity. the improvement in the cct110 % per-
formance and not the rSA protocol may be a reflection of 
the modality of HIE which may influence metabolism dif-
ferently and consequently have different impacts on intra-
cellular and extracellular buffering systems. Furthermore, 
it could demonstrate that fatigue may not be pH related in 
some instances of HIE.
Muscle carnosine concentrations increased by 62 and 
88 % in the gastrocnemius and soleus, respectively, fol-
lowing 6 weeks of supplementation with β-alanine. this 
is comparable to direct measures in vastus lateralis biop-
sies of untrained subjects (Harris et al. 2006; Hill et al. 
2007) and indirect MrS gastrocnemius and soleus muscle 
of both trained (Derave et al. 2007) and untrained males 
(Baguet et al. 2009), following chronic supplementation of 
β-alanine. the increase in carnosine content in the current 
study was higher than previous reports using MrS tech-
nology, with Baguet et al. (2009) showing a 23 and 39 % 
increase, and Derave et al. (2007) a 37 and 47 % increase 
in the gastrocnemius and soleus muscles, respectively. this 
may be due to differences between β-alanine supplementa-
tion protocols where 6 weeks and a total dosage of 224 mg 
were utilised in this study compared to shorter duration and 
lower dosages implemented in previous studies.
the efficacy of the naHcO3 supplementation employed 
in this study was demonstrated by a significant increase 
in blood HcO3− following the 90-min pre-exercise sup-
plementation period in both the BAl-SB and Pl-SB groups 
Fig. 4  Blood pH recorded for 
the different groups during the 
repeated sprint ability (rSA) 
and cycling capacity test 
(cct110 %). Values expressed 
as mean ± SEM. *p < 0.05 
BAl-SB and Pl-SB from Pl–Pl, 
#p < 0.05 BAl-SB and Pl-SB 
from PreEx0, +p < 0.05 BAl-SB 
from Pl–Pl, thick vertical bar 
denotes exercise
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Table 1  Peak power output 
(PPO) and average power 
output (APO) (W) achieved 
for each of the 5 × 6 s sprints 
between supplement groups 
during the repeated sprint 
ability (rSA) test
Values expressed as 
mean ± SEM
BAl-Pl BAl-SB Pl–Pl Pl-SB
PPO (W)
 Sprint 1 987 ± 74.70 970 ± 71.32 1,028 ± 70.53 1,000 ± 72.20
 Sprint 2 969 ± 75.43 976 ± 84.57 989 ± 73.16 1,018 ± 70.28
 Sprint 3 948 ± 72.27 946 ± 78.04 966 ± 61.07 969 ± 58.40
 Sprint 4 933 ± 72.72 927 ± 69.18 938 ± 58.96 911 ± 58.60
 Sprint 5 884 ± 73.99 884 ± 60.74 913 ± 51.96 904 ± 64.19
APO (W)
Sprint 1 803 ± 67.13 813 ± 64.23 873 ± 73.35 857 ± 64.13
 Sprint 2 774 ± 61.74 792 ± 56.67 826 ± 69.25 826 ± 60.50
 Sprint 3 732 ± 59.13 749 ± 59.51 773 ± 62.57 757 ± 61.34
 Sprint 4 709 ± 54.24 705 ± 57.31 749 ± 57.35 721 ± 56.57
 Sprint 5 672 ± 55.40 690 ± 53.18 710 ± 46.26 684 ± 56.45
CCT110%
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Fig. 5  time to exhaustion (ttE) (s) results for the different sup-
plement groups during the cycling capacity test (cct110 %). Values 
expressed as mean ± SEM. *p < 0.05 from Pl–Pl
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compared to placebo (Fig. 3). the elevation in blood 
HcO3− in the current study (5.99 mmol l−1) follow-
ing naHcO3 ingestion was of a similar magnitude to the 
mean increase of 5.3 mmol l−1 reported in a meta-analy-
sis of human naHcO3 loading studies which also used a 
300 mg kg−1 dose (Matson and Vu tran 1993). Although 
other investigations have reported plasma pH increases 
of ~0.05 units following similar HcO3− supplementation 
regimes, discrepancies in HIE performance have resulted in 
either positive (Bishop et al. 2004; lindh et al. 2008; Sie-
gler et al. 2010) or no change (Matsuura et al. 2007; Price 
et al. 2003; Sale et al. 2011). A lack of change in blood pH 
between pre-acute supplementation and pre-exercise was 
observed in this study, indicating that despite a significant 
rise in blood HcO3−, metabolic alkalosis was not being 
achieved (see Fig. 4).
Ingestion of naHcO3 elevated blood pH by ~0.07 pH 
units 60 min following exercise in both HIE tests, along 
with a tendency to cause higher blood HcO3− concentra-
tions. this suggests that a longer time between acute sup-
plementation and exercise commencing may have been 
more suitable in this study to induce an alkalotic state, 
which may in turn assist in improving HIE performance 
parameters. Extended ingestion protocols (>90 min) have 
been previously investigated, with metabolic alkalin-
ity achieved prior to exercise; however, the performance 
enhancing abilities of naHcO3 even with longer supple-
mentation protocols employed remain equivocal (gaitonos 
et al. 1991; Sale et al. 2011).
to our knowledge, this is the first study to examine the 
co-ingestion of β-alanine and naHcO3 on intermittent 
HIE performance parameters. PPO and APO were not dif-
ferent between treatment groups during each of the 5 × 6 s 
sprints performed during the rSA test, or in terms of total 
work performed. gaitonos et al. (1991) also reported that 
naHcO3 supplementation did not induce performance 
benefits when using a similar exercise protocol (10 × 6 s 
sprints every 36 s) in male subjects. Although gaitonos 
et al. (1991) assessed running performance, rather than 
cycling performance as used in this study; both used simi-
lar metabolic pathways in order for the effect of supple-
mentation to be seen (Fitzsimons et al. 1993). this is con-
trary to an identical rSA exercise protocol employed by 
Bishop et al. (2004) demonstrating that the oral ingestion 
of naHcO3 in active female hockey players increased PPO 
compared to the placebo condition during the last three of 
the 5 × 6 s sprints performed, indicating a potential spe-
cific conditioning of training-dependant response.
Sweeney et al. (2010) examined the effect of 5 weeks 
β-alanine supplementation using a similar total dose (224 
vs. 238 g) on rSA in active males. consistent with the 
present findings, β-alanine supplementation alone did not 
influence repeat sprint performance, with no change in 
power output observed. co-ingestion with naHcO3 in our 
study was unable to improve performance, demonstrating 
no influence of the treatment strategy on intermittent HIE.
the absence of a difference between treatments indi-
cates either a potential gain in both intra- and extracellu-
lar buffing capacity, represented by observed elevations in 
muscle carnosine and blood bicarbonate, was either insuf-
ficient to bring about an increase in performance, or that 
decreases in pH is not the predominant limiting factor in 
intermittent HIE. Previous research observing high-inten-
sity repeated sprint performance has also attributed fatigue 
to the availability and resynthesis of phosphocreatine 
(Pcr), in addition to the effects of acidosis (Derave et al. 
2010; Sweeney et al. 2010). During a single bout (6 s) of 
high-intensity exercise, the utilisation of Pcr and anaerobic 
glycolysis each account for a majority of the energy source 
required (Sweeney et al. 2010). repetition of short-dura-
tion sprints may result in a greater depletion of Pcr than 
would occur during a single maximal effort (Derave et al. 
2007). the rest between sprints during the rSA (24 s) may 
not have been long enough to resynthesis Pcr, as this pro-
cess typically takes minutes rather than seconds (Derave 
et al. 2007). Hence, it is possible that Pcr depletion may 
have been a greater cause of fatigue than acidosis during 
the rSA protocol implemented (5 × 6 s interspersed with 
24 s rest), and as a result, any potential ergogenic effects 
of β-alanine and naHcO3 as physiochemical buffers during 
intermittent HIE may not have been detectable.
β-alanine supplementation significantly increased ttE 
during the cct110 % test with a 14 % improvement. this 
compares favourably with identical continuous HIE cycling 
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Fig. 6  Plasma lactate concentration (mmol l−1) for the different sup-
plemental groups during the cycling capacity test (cct110 %). Values 
expressed as mean ± SEM. *p < 0.05 BAl-SB from Pl–Pl. Thick ver-
tical bar denotes exercise
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protocols implemented by Sale et al. (2011) who also 
reported a 15 % increase following a 4-week supplemen-
tation period, and Hill et al. (2007) who showed a 13 % 
increased enhancement in ttE 4 weeks following supple-
mentation, with a further 3 % increase after a 6-week sup-
plement extension. cycling capacity protocols, such as the 
one employed in these studies, can be considered beneficial 
as they induce a large accumulation of acidic by-products 
resulting in a drop in intracellular pH, such that the poten-
tially ergogenic effects of β-alanine are influential.
In contrast to the effect of β-alanine on continuous HIE, 
naHcO3 ingestion alone did not improve performance 
parameters relative to that of the Pl–Pl condition. Earlier stud-
ies show no effect of naHcO3 on exercise performance using 
cycling protocols where participants cycle to exhaustion at 
both 110 % (robergs et al. 2005; Sale et al. 2011) and 120 % 
Wmax (Siegler et al. 2007) has previously been observed, 
despite the clear stimulus of increased H+ production in the 
working muscle cells. consistent with the report of Sale et al. 
(2011), the results of this investigation support the ability to 
increase continuous HIE capacity following the co-ingestion 
of β-alanine and naHcO3 above that of naHcO3 alone, but 
not compared to β-alanine alone, with only a 2 % increase 
(~3 s) in ttE attained. Whilst this magnitude of elevation 
was not statistically significant (with 95 % confidence limits), 
it could be postulated that in terms of athletic performance 
small increases in ttE may still be important.
An increased buffering capacity may improve metabolic 
conditions for sustained elevated glycolytic energy pro-
duction during the final stages of maximal effort exercise, 
and result in elevation of lactate ions in the active muscles 
and blood (Price and Simons 2010; Siegler et al. 2010; Van 
thienen et al. 2009). Immediately following both the rSA 
test and cct110 %, plasma lactate values were not different 
between groups. However, 5 min following the cct110 % 
(Fig. 6), a marked increase in plasma lactate was observed 
in naHcO3 supplemented groups compared with Pl–Pl, 
significant only in the BAl-SB treatment.
the lack of any observed change in plasma lactate con-
centration between the BAl-Pl and Pl–Pl groups following 
both the rSA and cct110 % exercise protocols, suggests that 
enhanced intracellular buffering capacity did not promote 
increased glycolytic metabolism. Others have also reported 
no change in plasma lactate following HIE post chronic sup-
plementation with β-alanine, although they did report per-
formance benefits (Sweeney et al. 2010). Improvements in 
ttE in the current studies cct110 % test may therefore indi-
cate a potential mechanism of action other than enhanced 
intracellular buffering capacity in which β-alanine may pro-
vide ergogenic effects during continuous HIE.
In summary, there was no aggregating effect of the com-
bined supplementation protocol on performance or metab-
olism, although the ingestion of β-alanine and naHcO3 
elevated both intra- and extracellular buffering capacity 
potential, by increasing concentrations of muscle carnos-
ine and blood HcO3−, respectively. Alterations in buffer-
ing potential did coincide with performance enhancements 
in continuous fatiguing exercise, with ttE improved fol-
lowing β-alanine supplementation. no changes were found 
in performance parameters between the treatment com-
binations during maximal intermittent sprint exercise. no 
change in blood pH following naHcO3 ingestion in the 
BAl-SB and Pl-SB groups demonstrates that an alkalotic 
state was not produced prior to exercise commencing, sug-
gesting that the time between acute feeding and exercise 
implemented in this study may not be long enough to alter 
extracellular alkalinity, which in turn may have limited the 
potential for performance improvements. this may indicate 
that pH may not be a mechanism that influences fatigue in 
all HIE protocols. Further investigations into the potential 
mechanisms in which β-alanine provide ergogenic effect 
during continuous HIE performance, including the role of 
muscle carnosine as an antioxidant, are warranted as other 
intramuscular influences such as alterations in rOS (by-
products of antioxidant effects) may play an influential role 
in potentially enhancing exercise performance.
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